Browse recalls
Search the latest U.S. consumer product recalls. Add the things you own to a watchlist to get notified.
36,805 recalls · page 158 of 1841
FDAAug 13, 2025 · #D-0567-2025
Class II — temporary health riskDuloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc., Berlin, CT 06037, NDC 61919-422-30
Drugs · 02AU2406
FDAAug 13, 2025 · #D-0562-2025
Class II — temporary health riskSemaglutide + Cyanocobalamin 0.88 mg + 0.25mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Ki...
Drugs
FDAAug 13, 2025 · #D-0555-2025
Class II — temporary health riskTirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirklan...
Drugs
FDAAug 13, 2025 · #D-0553-2025
Class II — temporary health riskSemaglutide + Cyanocobalamin 0.22 mg + 0.25mg/0.5 ml Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirklan...
Drugs
FDAAug 13, 2025 · #D-0574-2025
Class II — temporary health riskSpironolactone Tablets, USP, 25 mg, 100-count bottle, Rx only, Mfg. by: Frontida BioPharm, Inc., 1100 Orthodox St, Philadelphia, PA 19124, Dist. by: Sun Pharmaceutical Industries, Inc., Cranbury, N...
Drugs · P3314
FDAAug 13, 2025 · #D-0554-2025
Class II — temporary health riskTirzepatide + Niacinamide 2.2 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland...
Drugs
FDAAug 13, 2025 · #D-0573-2025
Class II — temporary health riskRECOMBINATE, [Antihemophilic Factor (Recombinant)], 5 mL vials, Rx Only, Takeda Pharmaceuticals USA, Cambridge, MA 02142, NDC: 00944-2843-01
Drugs · TRB23802AC
FDAAug 13, 2025 · #D-0558-2025
Class II — temporary health riskTirzepatide + Niacinamide 11.24 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirk...
Drugs
FDAAug 13, 2025 · #D-0566-2025
Class II — temporary health riskDoxepin Hydrochloride Capsules, USP, 10 mg, 100 Capsules, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panela v 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc....
Drugs · 2305015142
NHTSAAug 12, 2025 · #25V523000
Vehicle safety defectLow Fuel Pressure May Stall Engine
Vehicle
NHTSAAug 12, 2025 · #25T015000
Tire safety defectMotorcycle Tires May Have Reduced Traction
Tire
NHTSAAug 12, 2025 · #25V525000
Vehicle safety defectHydraulic Fluid Leak May Cause a Fire
Vehicle
NHTSAAug 12, 2025 · #25V524000
Vehicle safety defectAutomatic Front Loader Arm May Crack and Fall
Vehicle
NHTSAAug 12, 2025 · #25V522000
Vehicle safety defectUnintended Movement Due to Parking Brake Tension Spring Failure
Vehicle
NHTSAAug 11, 2025 · #25V521000
Vehicle safety defectLoss of Steering Control
Vehicle
NHTSAAug 11, 2025 · #25V520000
Vehicle safety defectLoss of Steering Control
Vehicle
NHTSAAug 8, 2025 · #25V519000
Vehicle safety defectHeadlights May Fail/FMVSS 108
Vehicle
NHTSAAug 8, 2025 · #25V518000
Vehicle safety defectWindow Automatic Reversal System Malfunction/FMVSS 118
Vehicle
NHTSAAug 8, 2025 · #25V517000
Vehicle safety defectParking Lights May Flicker/FMVSS 108
Vehicle
NHTSAAug 8, 2025 · #25V516000
Vehicle safety defectBlank Instrument Panel Display/FMVSS 101 & 102
Vehicle